Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Intervention to Retain HIV-positive Patients in Medical Care
NCT01537367 · View on ClinicalTrials.gov ↗
Study Summary
PROJECT OVERVIEW This research is a collaboration between the Centers for Disease Control and Prevention (CDC), the Health Resources and Services Administration (HRSA), and six university-affiliated HIV clinics in the United States. Study title: Intervention Trials to Retain HIV Patients in Medical Care Study sites: The study will be performed at six HIV clinics affiliated with academic medical centers. Objectives: Using HIV patients' clinical data (without personal identifiers) routinely archived in electronic databases at the six participating clinics do the following: • To examine the extent to which a client-centered intervention delivered by trained interventionists (Phase 2 trial of the project) improves patient attendance for HIV primary care over and above the effect of the clinic-wide intervention. Phase 2 is a three-arm randomized controlled trial conducted at each of the participating six clinics. 300 patients will be enrolled in the Phase 2 trial at each clinic. One hundred will be new patients and 200 will be patients with inconsistent attendance for HIV primary care at the clinic in the prior 12 months. Patients will be randomized to: (1) an enhanced contact plus behavioral skills arm or (2) an enhanced contact-only arm in which patients will receive a longer or a shorter client-centered intervention from two trained interventionists, or (3) the standard of care arm in which patients will receive the clinic-wide intervention and routine HIV clinical care only.
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Enhanced contact plus behavioral skills
- BEHAVIORAL Enhanced contact only
Study Locations (6)
Alabama
- 1917 Clinic of the University of Alabama-Birmingham — Birmingham
Florida
- Adult HIV Clinic of the Jackson Health System — Miami
Maryland
- Moore Clinic of the Johns Hopkins University Medical Institutions — Baltimore
Massachusetts
- Boston University Medical Center, HIV Clinic — Boston
New York
- SUNY Downstate Medical Center, STAR Health Center — Brooklyn
Texas
- Baylor College of Medicine-Thomas Street Health Center — Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,838 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01537367
The ClinicalTrials.gov registry entry for NCT01537367 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,838 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 42 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Primary Care Appointment Keeping appearing as the primary indexed condition, and to 3 interventions — of which Standard of Care is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT01537367 reports 6 study locations spanning 6 distinct geographic areas — top geographies include Alabama, Florida, Maryland. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT01537367 about?
NCT01537367 is a clinical study titled "Intervention to Retain HIV-positive Patients in Medical Care". PROJECT OVERVIEW This research is a collaboration between the Centers for Disease Control and Prevention (CDC), the Health Resources and Services Administration (HRSA), and six university-affiliated HIV clinics in the United States. Study title: Intervention Trials to Retain HIV Patients in Medica...
What is the current status of trial NCT01537367?
This trial is currently completed. It is a NA study. The enrollment target is 1,838 participants. The study started on 2010-07. Estimated completion is 2012-02.
What conditions does trial NCT01537367 study?
This clinical trial studies the following conditions: Primary Care Appointment Keeping. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT01537367?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Enhanced contact plus behavioral skills (BEHAVIORAL), Enhanced contact only (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT01537367?
This trial is sponsored by Centers for Disease Control and Prevention, which has 42 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT01537367 being conducted?
This trial has 6 study locations across Alabama, Florida, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.